Lithium vs placeboEfficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania1 finding from 1 reviewLithium for acute mania 2019 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 935 participantsHigh
Lithium vs QUETIAPINEEfficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania1 finding from 1 reviewLithium for acute mania 2019 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 359 participantsLow
Lithium vs carbamazepineEfficacy: response (continuous) YMRS/BPRS change from baseline to end of study · acute mania1 finding from 1 reviewLithium for acute mania 2019 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 102 participantsVery low
Lithium vs all antimanic agentsEfficacy: response (continuous) YMRS/BPRS change from baseline to end of study · acute mania1 finding from 1 reviewLithium for acute mania 2019 · Cochrane Headline outcomes onlyno estimate extracted19 studies · 2410 participantsLow
Lithium vs valproateEfficacy: response (continuous) Change in YMRS (ITT‐LOCF) from baseline to end of study · acute mania1 finding from 1 reviewLithium for acute mania 2019 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 398 participantsVery low